This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Infosys Commits To End Child Diarrheal Deaths In India

Stocks in this article: INFY

BANGALORE, India, August 22, 2012 /PRNewswire/ --

 

Infosys Labs to Solve Critical Maternal and Child Health Challenges, in Support of the UN Secretary-General's Every Woman Every Child Movement

Infosys, a global leader in consulting and technology, today announced that it has made a commitment to work with the MDG Health Alliance, the United Nations Foundation, and the Clinton Health Access Initiative as an Innovation Partner for the India Public-Private Partnership to End Child Diarrheal Deaths, in support of the United Nations Secretary-General's Every Woman Every Child movement. Under this program Infosys Labs, the research and innovation arm of Infosys, will institute an Innovation Co-creation Lab to explore ways that technology can be used to solve critical maternal and child health challenges.

Every Woman Every Child is an unprecedented global movement spearheaded by the UN Secretary-General to mobilize and intensify global action to improve the health of women and children. In India, the effort is supported by the India Publicā€Private Partnership to End Child Diarrheal Deaths, with a vision to prevent deaths of more than 200,000 children under five years of age every year. This partnership will mobilize public and private sector stakeholders to achieve universal coverage of children in India through the intervention of oral rehydration solution (ORS) and zinc by 2015, thereby playing a critical role in preventing diarrheal deaths.

As Innovation Partner for the India Public-Private Partnership to End Child Diarrheal Deaths, Infosys is collaborating with the MDG Health Alliance, United Nations Foundation and the Clinton Health Access Initiative. The Innovation Co-creation Lab created by Infosys will facilitate the convergence of the initiative's task force members onto a common forum offering tools, platforms, frameworks and processes to organize, manage and assist the co-creational interactions specific to this partnership.  

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,383.68 -295.02 -1.67%
S&P 500 2,035.42 -21.67 -1.05%
NASDAQ 4,701.7520 -70.0110 -1.47%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs